Axonics Inc

NASDAQ:AXNXUnited States

Axonics, Inc. is a medical technology company, which develops and commercializes products to treat bladder and bowel dysfunction. It has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10 cubic centimeters (cc) in volume, utilizes constant current stimulation, a recharge-free patient remote control and offers broad magnetic resonance imaging (MRI) access. Its SNM systems include an easy-to-use wireless patient remote control that does not require recharging or replacement batteries. It also offers a clinician programmer that guides the implanting physician through lead placement and stimulation programming.

Contact Information

Headquarters

26 Technology DriveIRVINE, CA, United States 92618

Phone

949-396-6322

Fax

949-396-6321

Executives

Independent Chairman of the Board

Michael Carrel

Chief Executive Officer, Director

Raymond Cohen

Chief Financial Officer

Kari Keese

Chief Operating Officer

Rinda Sama

Executive Vice President, Chief Marketing and Strategy Officer

John Woock